用水作为药物,在使用阿金氨酸类似物的血清蛋白酶中专门针对S1口袋
Haili Lin1, Mingming Xu2, Longguang Jiang3
1Department of Pharmacy, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Bioorganic chemistry
|August 21, 2024
概括
新的阿基尼类同类药物被开发用于改进针对蛋白酶的受体抑制剂. 这些类似物通过利用S1口袋中新发现的水通道机制来增强抑制剂的功效和特异性.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 血清蛋白酶具有很高的结构相似性,因此S1口袋分化由于在残留190 (A190/S190) 的变异性而具有挑战性.
- 现有的使用氨酸或氨酸P1残留物的类抑制剂对S1口袋变体缺乏特异性.
研究的目的:
- 设计用于抑制剂的新型P1残留物,以增强对血清蛋白酶的效能和特异性.
- 阐明S1口袋变体的抑制剂特异性背后的分子机制.
主要方法:
- 在抑制剂中合成和测试新型阿尔金因类型 (12和16) 作为P1残留物.
- 结晶学和分子动力学模拟以调查结合相互作用和机制.
- 对各种血清蛋白酶的亲和度测量.
主要成果:
- L-3-(N-amidino-4-piperidyl) alanine (16) 广泛增强了蛋白酶抑制.
- L-4-guanidinophenylalanine (12) 特别提高了对蛋白酶的亲和力,与S190.
- 在S1口袋底部发现了一种新型的水交换通道,该通道由残留物190调节.
- 抑制剂12的特异性与这种水通道有关.
结论:
- 新的P1残留物 (12和16) 可以通过工程改造来提高血清蛋白酶抑制剂的强度和特异性.
- 涉及S1口袋的残留物190和水通道的水介导机制决定了抑制剂的特异性.
- 这项工作为开发向的血清蛋白酶抑制剂提供了新的工具和见解.
相关概念视频
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
547
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
547
02:40Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
522
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
522